Oral Vinorelbine or Capecitabine Combined With Trastuzumab as Adjuvant Treatment for Patients With Lymph Node Negative, HER-2 Positive and Small Tumor Size Breast Cancer (ORCHID)
Clinical trial NCT04296162 · COMPLETED
Trial details
- NCT number
- NCT04296162
- Sponsor
- Fudan University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-10
- Primary completion
- 2026-04-25
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.